EFSA Launches Full Re-evaluation of the Effects of Bisphenol A

25 Apr 2012 --- Experts on EFSA’s Panel on Food Contact Materials, Enzymes, Flavorings and Processing Aids (CEF) will further evaluate uncertainties about the possible relevance to human health of some BPA-related effects observed in rodents at low dose levels.

25 April 2012 --- The European Food Safety Authority (EFSA) has started work on its new risk assessment of bisphenol A (BPA), used in food contact materials, focusing in particular on exposure of vulnerable groups. The new opinion will complement earlier scientific advice provided at the request of the European Commission. EFSA will review all the available data and scientific studies on dietary exposure published since its 2006 opinion on BPA and also take into consideration the contribution of non-dietary sources to overall exposure to BPA.

Experts on EFSA’s Panel on Food Contact Materials, Enzymes, Flavorings and Processing Aids (CEF) will further evaluate uncertainties about the possible relevance to human health of some BPA-related effects observed in rodents at low dose levels. New findings from ongoing studies on low dose effects as well as on dietary and non-dietary exposure to BPA will be considered as they become available during 2012. EFSA is also convening a Colloquium of international experts to debate the most recent scientific evidence of low dose effects in toxicology and the challenges this poses for risk assessment.

At its February 2012 plenary meeting the CEF Panel proposed a co-ordinated work plan for the full re-evaluation of the human risks associated with exposure to BPA through the diet by May 2013. This initiative was taken in light of EFSA’s ongoing monitoring of scientific research on BPA and the CEF Panel’s further consideration of new scientific studies. Two multidisciplinary working groups of experts have been established to focus, respectively, on the hazard characterization of BPA (concerning its toxicological effects) and on exposure to BPA (how and how much BPA is absorbed by the human body). To enhance EU-wide cooperation, experts from national authorities undertaking related scientific work on BPA have also been invited to contribute to the working groups.

In recent years, efforts have been made to reduce exposure to BPA, particularly for vulnerable population groups such as infants, children and pregnant women, and baby bottles made of BPA-containing polycarbonate plastics have been banned. EFSA will launch a call for data from Member States to provide an up-to-date indication of the occurrence of BPA in food as well as the amount of BPA residue that migrates from food contact materials into food.

In carrying out this comprehensive risk assessment EFSA will also liaise with scientific experts in the Member States and in the United States on risk assessment reports in preparation and on large scale studies currently in progress. Further, EFSA will specifically tackle the issue of low dose effects in toxicology and risk assessment at its dedicated Scientific Colloquium, taking place in Parma on 14-15 June; several leading scientists from Europe and North America have already confirmed their attendance. Registration for the Colloquium is open until 30 April 2012 or until seating capacity is filled.

Related Articles

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

Nutrition & Health News

L-Carnitine – "Unquestionable" room for market growth: Lonza

08 Feb 2018 --- From facilitating the recovery process in the sports nutrition sector to improving energy metabolism in healthy aging products, L-Carnitine has proven itself a versatile ingredient with the potential to be applied in myriad applications. “Sports nutrition, weight management, all these areas are still growing. There is no question that there is a lot of room for L-Carnitine’s development. We see a lot of demand coming from Asia and Africa for infant food applications. The other big market is for sure energy drinks,” Marco Gossen, Business Development Manager at Lonza, explains during a NutritionInsight webinar last week, looking at product development and untapped opportunities for L-Carnitine.

Business News

Probi signs agreement with “global FMCG company” on gut health launch, enjoys Asia-Pacific growth

26 Jan 2018 --- Probi is seeking to further expand into the functional food space with a newly signed agreement with an as-of-yet unnamed global FMCG company. The partnership relates to the launch of a product containing Probi’s bacteria for gut health in North America. In its year-end report, Probi [which is majority owned by Symrise] notes that a launch in the North American market is planned for the second half of 2019, potentially followed by launches in other territories. The agreement is expected to have a significant impact on future sales and earnings in Probi’s Functional Food business area. 

Nutrition & Health News

Banken Champignons to launch vitamin D mushrooms 

26 Jan 2018 --- Dutch mushroom supplier Banken Champignons has received a green light from the European Food Safety Authority (EFSA) to launch vitamin D mushrooms on the European market. According to the company, a single serving of this new mushroom variant can provide the RDA of 10 micrograms of vitamin D. 

Regulatory News

EFSA rejects Unilever black tea health claim

18 Jan 2018 --- The European Food and Safety Authority (EFSA) has rejected a health claim regarding black tea’s effects on the maintenance of normal endothelium-dependent vasodilation in adults. The application, submitted for authorization of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 by Unilever, pertained to “black tea beverages, either freshly prepared or reconstituted from water extract powders of black tea, characterized by the content of flavanols (expressed as catechins plus theaflavins) of at least 30 mg per 200 ml serving.” 

More Articles
URL : http://www.nutritioninsight.com:80/news/EFSA-Launches-Full-Re-evaluation-of-the-Effects-of-Bisphenol-A.html